The Recall Desk
ModerateFDA (Drugs)·D-1158-2022·Announced 2022-06-22

Artri Ajo King Tablets Recalled for Unapproved Drug Claims

Walmart is recalling all lots of Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets nationwide. The product was marketed without FDA approval based on unapproved labeling claims.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall involving labeling non-compliance and unapproved drug claims. No reported illnesses, injuries, or hospitalization are documented. The hazard is regulatory non-compliance rather than a specific product safety defect.

Plain-English summary

Walmart Inc. is recalling all lots of Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, 100-count bottles (UPC 7 501031 12705), distributed nationwide in the USA. The recall involves 1,308 bottles total.

The FDA found that all lots of this product were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). The product was classified as an unapproved drug based on its labeling claims.

Consumers who have purchased this product should discontinue use and discard it. Anyone who has taken this product and has concerns should contact their healthcare provider.

The recalled product

Product
Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7 501031 12705.
Manufacturer
Walmart Inc
Category
Drug
Hazard
  • unapproved-drug
  • labeling-non-compliance

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All product lots.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category